---
title: "NHS Framework for the North of England, Branded Medicine"
ocid: "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2023-08-08"
---

# NHS Framework for the North of England, Branded Medicine

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599.json)

## Summary

The NHS England has awarded a contract for the NHS Framework for the North of England, Branded Medicine. The procurement process was conducted using an open procedure. The contract value is £431,836,170 GBP, and the contract period is from 1st March 2022 to 29th February 2024. The tender had a deadline on 20th October 2021. The procurement is in the pharmaceutical products category and is suitable for small and medium-sized enterprises (SMEs). The contract was awarded to multiple suppliers including Thornton and Ross Ltd, Janssen-Cilag Ltd, Biogen, and others.

This procurement opportunity for the NHS Framework for the North of England, Branded Medicine presents a significant chance for businesses to provide goods and services to NHS England. Companies operating in the pharmaceutical products industry would be well-suited to compete for this contract. The framework contract covers various regions in the UK, providing opportunities for suppliers across different areas including the East Midlands, London, North East, and more. With a focus on branded medicines, this tender offers a platform for growth and collaboration for both large-scale suppliers and SMEs.

## Notice

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure (above threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 8 Aug 2023 |
| Submission deadline | 20 Oct 2021 |
| Future notice date | Not specified |
| Award date | 7 Feb 2022 |
| Contract period | 1 Mar 2022 - 29 Feb 2024 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £431,836,170 |
| Lots value | Not specified |
| Awards value | £238,913,892 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 31 |
| Supplier names | ACCORD-UK; AMGEN; ASTRAZENECA; AVENTIS PHARMA LTD T/A SANOFI; BAYER; BIOGEN; BRISTOL MYERS SQUIBB; CELLTRION HEALTHCARE UNITED KINGDOM; CST PHARMA; ELI LILLY; GEDEON RICHTER; GILEAD SCIENCES; GLAXOSMITHKLINE; IPSEN; JANSSEN-CILAG; MERCK SERONO; MERCK SHARPE & DOHME (UK; MYLAN; NAPP PHARMACEUTICALS; NOVO NORDISK; ORGANON PHARMACEUTICALS; PFIZER; ROCHE PRODUCTS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; TEVA; THORNTON AND ROSS; UCB PHARMA; UL GLOBAL PHARMA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 8 Aug 2023 at 16:07 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd
- 15 Jul 2022 at 09:03 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/4e1189ae-e35a-4e20-a372-9d94847b46e3
- 1 Mar 2022 at 12:24 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/484b6e5e-50cb-4000-bdd3-ebf21ebdc232

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd
  8th August 2023 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/4e1189ae-e35a-4e20-a372-9d94847b46e3
  15th July 2022 - Awarded contract notice on Contracts Finder
- https://www.contractsfinder.service.gov.uk/Notice/484b6e5e-50cb-4000-bdd3-ebf21ebdc232
  1st March 2022 - Awarded contract notice on Contracts Finder
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iso2/JUvAXEmjfS6f.mMOhTbVfIHEXs5HDHgSPuYrNIpo6XY
  022928-2021 - FTS Contract Notice for CM_PHR_20_5600
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnp/Xxwt6Xq_QWObNFnX4EoxJMUc_XbDGhXCKHrDE9qgZRE
  Document No.10 Participating Authorities
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnq/k6sG9mcV2GkckTEI1To4GrwIUSpmgDNrh93hLpFGvbY
  Parties appointed to the framework agreement
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnx/kOVRqTlgfxNepxyyU.B61imwHnc_UAO6QPbxYotDQaw
  03. Framework Agreement and Terms and Conditions (1)
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isne/YID087kO.nMwTyYG2SOwhCawP2nL9HGlEjmt1ulNxo0
  CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isni/7TSKOEPze045lwL2BjsYIf89RcESghZ_8jvRhywstRM
  CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isno/xRBdJdiAS85GPqlCrT8Ogdj.rQZyf7EZWacC6sWPPLA
  CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnn/Cry_SEgf23Qx_MviISVwJ1hSAtxWyJz_fYd2hj7gUnI
  CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnd/vtfa5O1MSUvyM6xpc3N0_MZitxwYjXFxC73R7ldCpo8
  CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e20ae3df-a776-4a0a-8b63-45dd0baa2c90
  022928-2021 - FTS Contract Notice for CM_PHR_20_5600
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c73000ad-5873-4fa6-998d-f1b1680a6fae
  Document No.10 Participating Authorities
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8f0efa68-d252-42b4-8ab5-b3ffe61a594d
  Parties appointed to the framework agreement
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/7f20c186-583f-4271-950e-2170371a94bb
  03. Framework Agreement and Terms and Conditions (1)
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/fd34110c-317a-47d2-82a0-84fde45e206a
  CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/301f5cb5-7fbd-4db5-b846-a17077ea0787
  CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/efd44b98-6e0d-4088-a099-bfe11bfc196c
  CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/bc00f9a2-975c-4a3c-9f60-937d2142fd4d
  CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/23a80d8b-f7d3-46f2-8cc3-9741776de433
  CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599.json.